A systematic assessment of the reporting quality of randomized controlled trials of surgical interventions for nephrolithiasis (2002−2023)

Introduction: We aimed to evaluate the reporting quality of randomized controlled trials (RCTs) for surgical interventions in stone disease across 2002–2023, extending two earlier reviews of the literature with a new 2018–2023 cohort. Previous assessments of the reporting quality of RCTs in nephrolithiasis have shown suboptimal adherence. Methods: Building on two prior studies, we conducted a comprehensive literature search for RCTs assessing surgical stone interventions. Four independent reviewers performed data abstraction in duplicate. Reporting quality was assessed using the 25-item Consolidated Standards of Reporting Trials (CONSORT) checklist, with each study scored from 0−25; the primary outcome was the mean score. Scores were compared across four time periods (2002–2006, 2007−2011, 2012–2017, and 2018–2023) using ANOVA in SPSS version 29. Results: Three hundred and thirty-one studies met inclusion criteria (2002−2006: 38, 2007−2011: 64, 2012−2017: 101, and 2018−2023: 128). The mean ± standard deviation CONSORT summary scores for the four time periods were 11.4±2.3, 12.1±2.4, 12.7±2.9, and 16.1±3.2, respectively (p<0.001). Reporting rates were lowest for reporting ancillary analyses (10.9%) and implementation of randomization (14.0%). Notable improvements over time (2002−2006 vs. 2007−2011 vs. 2012−2017 vs. 2018−2023) were seen for trial registration (0% vs. 0% vs. 13.9% vs. 40.6%, p<0.001) and funding source (5.1% vs. 9.2% vs. 13.9% vs. 62.5%, p<0.001), respectively. Conclusions: The reporting quality of RCTs of surgical interventions for nephrolithiasis has improved, but critical methodologic domains remain underreported. Greater awareness of transparent trial reporting is needed.

Authors

Institutions

Publication Details

Journal
Canadian Urological Association Journal
Published
2026-11-20
DOI
https://doi.org/10.5489/cuaj.9727
Primary Topic
Meta-analysis and systematic reviews
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A systematic assessment of the reporting quality of randomized controlled trials of surgical interventions for nephrolithiasis (2002−2023)

Philipp Dahm, Evelyn Arden, Keianna Vogel, Daniel Turin et al.
1 links
Canadian Urological Association Journal
Meta-analysis and systematic reviews
article

A systematic assessment of the reporting quality of randomized controlled trials of surgical interventions for nephrolithiasis (2002−2023)

Philipp Dahm, Evelyn Arden, Keianna Vogel, Daniel Turin, Michael Thompson
article en

Abstract

Introduction: We aimed to evaluate the reporting quality of randomized controlled trials (RCTs) for surgical interventions in stone disease across 2002–2023, extending two earlier reviews of the literature with a new 2018–2023 cohort. Previous assessments of the reporting quality of RCTs in nephrolithiasis have shown suboptimal adherence. Methods: Building on two prior studies, we conducted a comprehensive literature search for RCTs assessing surgical stone interventions. Four independent reviewers performed data abstraction in duplicate. Reporting quality was assessed using the 25-item Consolidated Standards of Reporting Trials (CONSORT) checklist, with each study scored from 0−25; the primary outcome was the mean score. Scores were compared across four time periods (2002–2006, 2007−2011, 2012–2017, and 2018–2023) using ANOVA in SPSS version 29. Results: Three hundred and thirty-one studies met inclusion criteria (2002−2006: 38, 2007−2011: 64, 2012−2017: 101, and 2018−2023: 128). The mean ± standard deviation CONSORT summary scores for the four time periods were 11.4±2.3, 12.1±2.4, 12.7±2.9, and 16.1±3.2, respectively (p<0.001). Reporting rates were lowest for reporting ancillary analyses (10.9%) and implementation of randomization (14.0%). Notable improvements over time (2002−2006 vs. 2007−2011 vs. 2012−2017 vs. 2018−2023) were seen for trial registration (0% vs. 0% vs. 13.9% vs. 40.6%, p<0.001) and funding source (5.1% vs. 9.2% vs. 13.9% vs. 62.5%, p<0.001), respectively. Conclusions: The reporting quality of RCTs of surgical interventions for nephrolithiasis has improved, but critical methodologic domains remain underreported. Greater awareness of transparent trial reporting is needed.

Canadian Urological Association JournalVol. 21(3)
University of Minnesota (US), Minneapolis VA Medical Center (US)
Good health and well-being
Meta-analysis and systematic reviews
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
A systematic assessment of the reporting quality of randomized controlled trials of surgical interventions for nephrolithiasis (2002−2023) — Philipp Dahm, Evelyn Arden, et al. · Canadian Urological Association Journal (2026) | TGRS Research Map | TGRS